Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Condition: Ischemic Stroke Interventions: Drug: mutant pro-urokinase; Drug: Alteplase Sponsor: Erasmus Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials